News Archives | Sysnav Healthcare

SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95 th Centile (SV95C) for Duchenne Muscular Dystrophy.

Learn More

EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy

Sysnav Healthcare is participating in the upcoming Rare Disease Endpoint Advancement Pilot Program Workshop.

Collaborative Article: “Evolving regulatory perspectives on digital health technologies for medicinal product development”

Sysnav Healthcare participation in DiMe’s V3+ project

Sysnav Healthcare announces a multi-year collaboration with Roche.

SYSNAV HEALTHCARE featured in the January 2023 Magazine of L’Usine Nouvelle.

Study Results with SV95C real-world data – Solid Biosciences